ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,289, issued on May 26.
"Lamotrigine oral liquid suspension and use thereof" was invented by Paul Sudhakar (Shawnee, Kan.) and Scott Boyer (West Chicago, Ill.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an oral liquid suspension that includes lamotrigine and methods of medical treatment that include administering the oral liquid suspension. The oral liquid suspension has desirable physicochemical properties and technical attributes. The oral liquid suspension is useful in patients having difficulties in swallowing tablets and provide medical practitioners with additional options for dose titration."
The patent was ...